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Release of conserved cytoplasmic proteins is widely spread among Gram-positive and
Gram-negative bacteria. Because these proteins display additional functions when located
at the bacterial surface, they have been qualified as moonlighting proteins. The GAPDH is a
glycolytic enzyme which plays an important role in the virulence processes of pathogenic
microorganisms like bacterial invasion and host immune system modulation. However,
GAPDH, like other moonlighting proteins, cannot be secreted through active secretion sys-
tems since they do not contain an N-terminal predicted signal peptide. In this work, we in-
vestigated the mechanism of GAPDH export and surface retention in Streptococcus
pneumoniae, a major human pathogen. We addressed the role of the major autolysin LytA
in the delivery process of GAPDH to the cell surface. Pneumococcal lysis is abolished in the
ΔlytA mutant strain or when 1% choline chloride is added in the culture media. We showed
that these conditions induce a marked reduction in the amount of surface-associated
GAPDH. These data suggest that the presence of GAPDH at the surface of pneumococcal
cells depends on the LytA-mediated lysis of a fraction of the cell population. Moreover, we
demonstrated that pneumococcal GAPDH binds to the bacterial cell wall independently of
the presence of the teichoic acids component, supporting peptidoglycan as a ligand to sur-
face GAPDH. Finally, we showed that peptidoglycan-associated GAPDH recruits C1q from
human serum but does not activate the complement pathway.
Introduction
According to a recent estimation, the human genome contains only 19 000 protein-coding
genes [1] while a higher number of proteins variants are required to account for the complex
regulatory proteins network that control the human organism. One way to generate the re-
quired protein function diversity is the splicing of eukaryotic gene. Alternatively, a protein may
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display multiple independent functions. This last concept has been termed the "moonlighting
hypothesis" [2].
Moonlighting proteins were first described in eukaryotic cells [3, 4, 5]. In bacteria, the first
identified moonlighting enzyme was glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in
group A streptococci [6]. To date, more than 300 moonlighting proteins have been reported in
the three domains of life [7, 8]. In bacteria, the first moonlighting proteins were identified in
pathogenic Gram-positive bacteria as putative virulence factors [9, 10] but Gram-negative and
non-pathogenic or commensal bacteria also display sets of moonlighting proteins. The bacteri-
al moonlighting proteins (90 referenced so far) are conserved enzymes which functions are re-
lated to metabolism (glycolysis and tricarboxylic acid cycle), molecular chaperonin, nucleic
acid modification and other cellular processes [10].
A number of pathogenic bacteria exploit GAPDH as a virulence factor [10, 11, 12]. Bacterial
GAPDH proteins display multiple functions that are not always shared among species despite
high sequence conservation, up to 90% protein sequence identity. GAPDH promotes bacterial
adhesion and invasion of host cells [6, 13] through interaction with plasminogen and conver-
sion to proteolytic-active plasmin. GAPDH contributes to the evasion from the immune
system [14, 15]. We recently described a novel function of GAPDH: we showed that the pneu-
mococcal GAPDH is a ligand for C1q, a key component of the classical complement pathway
of the innate immune system [16].
The Gram-positive bacteria Streptococcus pneumoniae, also called pneumococcus is an im-
portant human pathogen that causes respiratory tract infections like pneumonia and sinusitis
but also invasive diseases such as septicemia and meningitis. This bacterium is responsible
worldwide for the death of around 1 million children under 5 years of age every year [17]. A
striking feature of the pneumococcus is that it uses more than 10 moonlighting proteins as vir-
ulence factors including GAPDH, like enolase, aldolase, PavA and PepO [18, 19, 20, 21, 22]
while other pathogenic streptococci, like S. pyogenes and S. agalactiae only exploit two in addi-
tion to GAPDH [23, 24, 25, 26].
Moonlighting proteins are involved in the virulence process of a wide range of pathogens
like Bacillus anthracis, Escherichia coli, Staphylococcus aureus, Listeria monocytogenes, Myco-
bacteria and almost all Streptococci ([27, 28, 29, 30, 31, 32, 10], and [11] for detailed reviews).
In all cases, the biological functions are carried out at the bacterial surface, which raises the
question of the mode of access to the cell surface of these cytoplasmic proteins. The absence of
signal peptide sequences excludes active secretion through the Sec and accessory SecA machin-
eries as well as through the Tat system. An alternative way is that moonlighting proteins would
be released from lyzed cells prior to binding to the surface of neighbouring bacteria.
In this work, we used the pneumococcal GAPDH as a moonlighting protein prototype to
test this hypothesis. Our data support an autolysin-mediated S. pneumoniae lysis process in the
release of GAPDH prior to binding to the peptidoglycan.
Results
GAPDH release in the culture medium requires pneumococcal lysis
We addressed the role of pneumococcal cell lysis in the delivery process of GAPDH to the cell
surface. Cell lysis is induced by hydrolytic enzymes belonging to the Choline-Binding Proteins
(Cbp) family, which are bound to the phosphorylcholine (PCho) molecules associated with cell
wall teichoic acids. Peptidoglycan hydrolytic enzymatic activities are harbored by LytA, LytC
and CbpD [33, 34, 35, 36]. LytA behaves as the major autolysin involved in pneumococcal lysis
since a lytAmutant strain does not display cell lysis [34] "Fig 1A". Another way to inactivate
cell wall hydrolytic function is to release the Cbps from the cell surface by adding competing
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Fig 1. Pneumococcal lysis induced by LytA promotes GAPDH surface localization. (A) Growth profiles of the R6 strain in CY and CY + 1% Cho and of
the R6 ΔlytAmutant in CY medium. (B) Bacterial suspensions of the R6 strain grown in CY and in CY + 1%Cho and the R6 ΔlytAmutant grown in CY were
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choline chloride in the culture medium. In these growth conditions, cell lysis is abolished to a
level comparable to the one observed with the lytAmutant strain "Fig 1A".
The quantity of GAPDH associated to the pneumococcal surface was evaluated by alkaline
elution of surface-attached proteins as described previously [16]. We checked that this proce-
dure did not trigger cell lysis using FtsZ, an abundant cytoplasmic protein as a cell lysis marker
"Fig 1B". When compared to the high quantity of cytoplasmic FtsZ "Fig 1B" (left panel, lane P),
very low FtsZ was detected in the alkaline elution fraction of the R6 strain while no FtsZ was
detected in the lytAmutant or when wild-type bacteria were grown in presence of 1% Cho "Fig
1B" (left panel, supernatant lanes). On the contrary, a large amount of GAPDH, almost equiva-
lent to the remaining cytoplasmic quantity, is eluted from the R6 cell surface, while no protein
was detected at the surface of the lytAmutant or in the presence of 1% Cho "Fig 1B" (right
panel). These data indicate firstly that the alkaline treatment allows the release of proteins asso-
ciated to the cell surface and preserves the cell integrity. Secondly, GAPDH is almost absent at
the surface of cells which lysis is impaired.
To confirm the latter observation, the relative amounts of GAPDH associated to the cell sur-
face of the R6 wild-type and lytA strains, and of the R6 wild-type strain grown in presence of
1% Cho were compared by Western blot and quantified. The amount of GAPDH was de-
creased by 70% in lytAmutant strain and by 65% when R6 cells were cultured in the presence
of 1% Cho when compared to the wild-type strain "Fig 1C". The released level of GAPDH was
analyzed at different time points during bacterial growth "Fig 1D". No GAPDH was detected at
the surface of the wild-type and lytAmutant strains, independently on addition of Cho, at the
early log phase (OD600nm 0.18, 80 min, data not shown). Increasing level of GAPDH was de-
tected at the surface of the wild-type strain from mid-log growth phase (OD600nm 0.43, 180
min) to late stationary phase (OD600nm 0.84, 380 min). In the context of the lytAmutant or
when the wild-type strain is cultured in presence of Cho, the level of GAPDH associated to the
cell surface was reduced by a factor 2 to 5 when compared to the wild-type strain in absence of
Cho. The quantity of GAPDH associated to the cell wall was also evaluated after subcellular
fractionation. As expected, the amount of GAPDH bound to the isolated cell wall was de-
creased in the lytAmutant strain and the wild-type strain grown in presence of 1% Cho by 60%
and 80%, respectively, when compared to the wild-type strain grown in CY "Fig 1E".
Altogether, these data show that the presence of GAPDH at the surface of pneumococcal
cells depends on the lysis of a fraction of the cell population mainly mediated by the major
autolysin LytA.
GAPDH released by cell lysis interacts with human complement factor
C1q
We previously showed that GAPDH exposed at the surface of the pneumococcus interacts
with the human components C1q [16]. This property was exploited to compare the level of sur-
face GAPDH in the WT and lytAmutant strains. Both strains, harvested from early logarithmic
treated by alkaline buffer to release surface-associated proteins. Proteins present in the pellet (P) fraction corresponding to the cytoplasmic extract and in the
alkaline supernatant fraction, which contains proteins detached from the cell surface, were analyzed byWestern blot using appropriate polyclonal antibodies.
Samples were analyzed on the same polyacrylamide gel. Left panel: detection of FtsZ (44.4 kDa) used to monitor the non-lytic effect of the alkaline treatment.
Right panel: detection of GAPDH (38 kDa). Equivalent amount of loading material was determined based on OD600nm values and gel scanning quantification
and not on CFUmeasurements since the chaining morphology of the R6 ΔlytAmutant and the one induced by the presence of 1% Cho alters colony counting
[65]. This procedure was also applied in experiments showed in Figs 1C, 1D and 1E. (C) Quantification of pneumococcal GAPDH associated to the bacterial
surface in the R6 strain grown in CY and in CY + 1% Cho and in the R6 ΔlytAmutant grown in CY. GAPDHwas detected byWestern blot and quantification
of the signal was performed. The average of three independent experiments is shown. (D) Same protocol as 1C. Amount of GAPDH associated to the cell
wall fraction at different stages of growth. (E) Same protocol as 1C. Amount of GAPDH associated to the cell wall fraction analyzed by subcellular
fractionation.
doi:10.1371/journal.pone.0125377.g001
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growth phase (OD600 0.3) and labeled with FITC were incubated with 1 μg of C1q coated on
96-wells plate. After extensive washes, the fluorescence associated to the plate was measured
which correlates with the level of bacteria bound to C1q "Fig 2". The interaction of the lytAmu-
tant strain with C1q is decreased by 63% when compared to the WT strain "Fig 2". This result
is consistent with the lower quantity of GAPDH exposed at the surface of the lytAmutant and
with the specific feature of GAPDH as being the unique pneumococcal ligand of C1q identified
so far [16]. Altogether, the data indicate that the GAPDH released through cell lysis mediated
by LytA is functional for C1q recognition.
Interaction of GAPDH to the pneumococcal cell wall
Association of moonlighting proteins, such as GAPDH, to the bacterial cell surface suggests
that the ligand might be a surface component shared among prokaryotes. We thus tested the
interaction of the pneumococcal GAPDH with purified cell wall composed of peptidoglycan
and teichoic acids.
We first measured the interaction of FITC-labeled GAPDH to sacculi "Fig 3A". The assay
specificity was evaluated by using control proteins originating from different organisms and se-
lected based on biochemical properties comparable to GAPDH, i.e. molecular masses and pI:
pneumococcal GAPDH (38 kDa, pI 5.78), Bovine Serum Albumin (BSA, 66 kDa, pI 5.6),
Glutathione-S Transferase (GST, 25.5 kDa, pI 6.09) and SOS-Green Fluorescent Protein
(SOS-GFP, 30.7 kDa, pI 5.8). Control proteins were also FITC-labeled and processed similarly
to the GAPDH. GAPDH displayed a four to five-fold higher level of cell wall binding when
compared to the control proteins "Fig 3A". Images of GAPDH-FITC bound to pneumococcal
Fig 2. Surface GAPDH promotes binding to C1q. Bacterial culture was withdrawn at mid-exponential
growth phase (OD600nm 0.3). FITC-labeled bacteria were incubated for 1 h at 4°C on 1 μg of C1q coated on
96-wells plate. After five washes, the fluorescence of FITC was measured. A representative experiment of 3
independent experiments is shown including the standard deviation of triplicate points. Significance was
determined by t-test analysis on 3 independent experiments.
doi:10.1371/journal.pone.0125377.g002
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sacculi are shown "Fig 3B". Pneumococcal sacculi, which conserve the ovococcal shape, were all
decorated by GAPDH-FITC but not by free-FITC molecules "Fig 3B". Pull-down of purified re-
combinant GAPDH with sacculi "Fig 3C" further demonstrated the association of GAPDH to
the pneumococcal cell wall.
Fig 3. Pneumococcal GAPDH binds to the cell wall. (A) Solid-phase binding assay of FITC-labeled
proteins to pneumococcal cell wall sacculi containing the peptidoglycan and the teichoic acids. (B)
Microscopic images of FITC-labeled GAPDH and FITC-free buffer used a negative control bound to
pneumococci cell wall sacculi. Phase contrast, fluorescence and merge pictures are shown. Scale bars,
5 μm. (C) Pull down of GAPDHwith pneumococcal cell wall. The load (L) protein was mixed with the insoluble
cell wall preparation. The supernatant (S) fraction containing unbound protein was recovered. After extensive
wash (W), protein bound to the cell wall pellet was eluted with Laemmli buffer at 100°C for 10 min (E). The
protein samples were analyzed byWestern blot using an anti-His tag antibody.
doi:10.1371/journal.pone.0125377.g003
Pneumococcal GAPDH Is Released by Cell Lysis and Binds Peptidoglycan
PLOS ONE | DOI:10.1371/journal.pone.0125377 April 30, 2015 6 / 17
Pneumococcal GAPDH binds to peptidoglycan
Apart from the capsule, the major polysaccharide components of the pneumococcal cell wall
are the peptidoglycan (PG) and teichoic acids (TA), the latter are either membrane or peptido-
glycan-anchored. Isolated pneumococcal cell wall preparations containing either the peptido-
glycan and the teichoic acids or only the peptidoglycan moiety were used to investigate the
respective role of both polysaccharides in GAPDH binding. As shown in Fig 4, purified
GAPDH interacts with peptidoglycan independently of the presence of the teichoic acids com-
ponents. Using synthetic lipoteichoic acids (LTA), no GAPDH binding could be detected.
C-Reactive Protein (CRP) is a well-known protein of the innate immune system, which recog-
nizes the PCho linked on teichoic acids moieties [37]. It was used in this experiment as an ar-
chetypal ligand for teichoic acids to ensure that the peptidoglycan cell wall preparation was
indeed free from detectable traces of teichoic acids. Altogether, these data support peptidogly-
can as the ligand of GAPDH at the surface of the pneumococcus.
Peptidoglycan-associated GAPDH recruits C1q from human serum but
does not activate the complement pathway
The data presented in this work indicate that GAPDH release is dependent from LytA-mediat-
ed cell lysis. Once exported, GAPDH associates to the bacterial surface through interaction
with the peptidoglycan component of the cell wall. We also provide evidence that cell surface-
exposed GAPDH interact with the complement factor C1q. This result is in accordance with
previous work in which we also showed the ability of surface-exposed GAPDH to activate the
complement pathway [16]. We sought to further investigate the role of GAPDH when associat-
ed to the bacterial cell wall. Purified GAPDH was incubated with pneumococcal sacculi only
composed of peptidoglycan. Human serum was added to the complex and the levels of C1q
and C4 deposited were measured "Fig 5". Peptidoglycan-associated GAPDH led to the deposi-
tion of about 5-fold more C1q than in absence of the protein, while no significant effect was
Fig 4. GAPDH binds to the peptidoglycan. A quantity of 100 μg of cell wall suspensions containing
peptidoglycan and the teichoic acids (PG+TA) or only peptidoglycan (PG) as well as purified lipoteichoic
acids (LTA) were coated on 96-well plate and incubated with GAPDH and the C-reactive protein (CRP). After
extensive washes, bound proteins were immunodetected using anti-GAPDH and anti-CRP sera.
Chemiluminescence was measured after extensive washes and expressed as arbitrary units. Each assay
was performed three times in triplicate wells. A representative experiment is shown.
doi:10.1371/journal.pone.0125377.g004
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observed with C4. This result suggests that peptidoglycan-bound GAPDH recruits C1q without
leading to complement activation.
Discussion
The rate of discovery of moonlighting proteins is increasing in all three domains of life as well
as the importance of their roles in physiological and pathological processes [38]. Release of
conserved cytoplasmic proteins is widely spread among Gram-positive and Gram-negative
bacteria. Indeed, proteomic analysis have identified glycolytic enzymes, chaperonins and trans-
lation factors in culture supernatant samples of Listeria, E. coli species [39, 40] and S. aureus
[41] as well as in cell wall enriched fractions of S. pneumoniae [42]. In pathogenic bacteria,
moonlighting proteins are exposed at the cell surface and are mostly involved in interaction
with host components. However, the mechanisms by which moonlighting proteins reach the
cell surface are still unknown. Since the moonlighting proteins display crucial and pleitropic
roles in virulence processes of a wide range of pathogenic microorganisms, the question of
their extracellular export and their mode of attachment to the cell surface is an important issue.
Pneumococcal GAPDH, like others moonlighting proteins can not be secreted through ac-
tive secretion systems since they do not contain an N-terminal predicted signal peptide. The
twin-arginine translocation export pathway is absent in S. pneumoniae, which excludes the use
of this system to export moonlighting proteins. The accessory secretion machinery SecA2, re-
quired for the secretion of a family of large serine-rich glycosylated proteins in Streptococci
and S. aureus [43] has been shown to be involved in the secretion of cytoplasmic proteins like
the superoxide dismutase A inM. tuberculosis [44] and autolytic enzyme in L.monocytogenes
[45]. So far, the SecA2 pathway has not been associated to the export of GAPDH proteins.
More importantly, a higher level of extracellular GAPDH was detected in S. agalactiae secA2
mutant when compared to the wild-type strain [46]. In S. pneumoniae, the SecA2 pathway is
present in a number of strains but absent in the D39 strain and its uncapsulated derivative
strain R6. Since the latter strain was used throughout this study, the universal role of the SecA2
pathway in secretion of moonlighting proteins in the pneumococcus can be excluded. Other se-
cretion systems present in Gram-positive bacteria like the type 4 secretion system [47] and the
type 4 pili are absent in S. pneumoniae [48]. The ubiquitous YidC system is known to insert a
subset of membrane proteins in the cytoplasmic membrane [49] and thus does not appear rele-
vant to translocate soluble proteins to the cell exterior. Specific Gram-positive systems like the
Fig 5. GAPDH increases C1q deposition on pneumococcal cell wall. Pneumococcal sacculi containing only peptidoglycan were deposited on 96-wells
plate and incubated with or without purified GAPDH. Normal human serum (NHS) was added and subsequent C1q and C4 deposition was measured using
anti-C1q and anti-C4 antibodies. A representative experiment of 2 independent experiments is shown including the standard deviation of triplicate points.
doi:10.1371/journal.pone.0125377.g005
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sortase system is not appropriate since these enzymes covalently attach proteins through a sort-
ing motif LPxTG to nascent peptidoglycan [50]. Finally, the Esx or type 7 secretion system is
absent in S. pneumoniae [51].
Cell lysis could be responsible for protein release in the extracellular medium prior to cap-
ture by the surface of live bacteria. Lysis of S. agalactiae cells mediated by detergent membrane
solubilisation or cell wall synthesis inhibition through the action of beta-lactam antibiotics led
to tens-fold increase of GAPDH associated to the cell surface [46]. Autolysis is a well-studied
phenomenon observed when bacterial cultures reach stationary phase and is mediated by ami-
dases, which cleave the bond between the N-acetylmuramic and the L-alanine residues of the
peptidoglycan. The S. aureusmajor autolysin Atl has been shown to play a role in excretion of
GAPDH since almost no protein was detected in the supernatant of atlmutant compared to
the wild-type strain, while in a tagOmutant, which harbors an increased cell lysis profile, the
amount of GAPDH in the supernatant was higher that in the wild-type strain [41]. We ob-
served comparable effects in pneumococcal cells deleted from the major autolysin LytA. Higher
quantity of GAPDH was detected at the surface of the wild-type strain when compared to the
lytAmutant strain, which does not undergo lysis after the stationary phase. Similar data were
obtained when cells were treated with an excess of choline chloride, which releases a family of
proteins bound to the choline residues associated to the teichoic acids. LytA is a member of
this Choline-Binding Proteins (Cbp) family as well as other cell wall hydrolases like CbpD and
LytC [34, 35, 36]. We thus provided evidence that the presence of GAPDH at the surface of
pneumococcal cells depends on the lysis of a fraction of the cell population mediated by the
autolysin LytA. Beside the possibility that moonlighting proteins might be released outside the
cell through cell lysis, the hypothesis that proteins might be secreted through a yet unidentified
machinery should be also considered. Insertion of a hydrophobic tail at the C-terminal end of
GAPDH in S. pyogenes prevented its export to the cell surface [52] Boël 2005). Deletion of a hy-
drophobic domain in B. subtilis enolase also affects surface exposition [53] Yang 2011). The
question about a possible regulation of the cytoplasmic proteins excretion remains also open.
To date, although some data suggest such process, not much is known. It was shown that auto-
modification of E. coli enolase by covalent binding of its substrate 2-phosphoglycerate affects
the enzymatic activity and was correlated to protein export [54]. A decreased active form of the
L.monocytogenes superoxide dismutase was observed upon serine/threonine phosphorylation
while the most active nonphosphorylated form was preferentially secreted via the SecA2 path-
way [55]. More generally, bacterial glycolytic enzymes, like enolase and GAPDH are commonly
detected in phosphoproteomic analysis but the physiological role of a putative post-translation-
al modification and its role in the extracellular export have not been investigated yet [56].
We checked if the presence of GAPDH at the surface of pneumococcal cells would not be an
indirect effect of protein abundance. A quantity of 2 200 molecules of GAPDH per cell ofMy-
coplasma pneumoniae had been measured [57] accounting for one of the most abundant pro-
teins. We compared the level of cell-surface exposed GAPDH to FtsZ, a cytoplasmic protein
involved in cell division, which abundance is of 3 000 molecules/cell in S. pneumoniae [58] and
about 4 000 molecules/cell in E. coli [59]. Almost no FtsZ was detected at the cell surface while
a large quantity corresponding to about the full cytoplasmic fraction of GAPDH was observed
at the cell surface indicating that the external presence of GAPDH is not related to non-specific
leakage of abundant proteins. These data are in accordance with observation in S. aureus,
where the abundance of proteins in the cytoplasm and their release into the supernatant are
two uncorrelated features [41].
Bergmann and Hammerschmidt were among the first to propose that moonlighting pro-
teins could associate to the cell surface after release from the cytoplasm based on the study of
pneumococcal enolase [60]. It was then shown that Lactococcus crispatus enolase and GAPDH
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bind to lipoteichoic acids [61]. Recently, the binding of S. agalactiae GAPDH to the bacterial
surface was demonstrated by adding recombinant purified GAPDH to heat-inactivated and
lived bacterial cells and to the surface of unrelated bacterial species, indicating that the surface
ligand would be common to many bacterial species [46]. Our data bring supplemental infor-
mation since we showed that the pneumococcal GAPDH binds to the peptidoglycan, the uni-
versal component of the bacterial cell wall.
Among the various roles played by bacterial GAPDH [11] one is dedicated to communica-
tion with the host immune system. GAPDH is involved in S. pyogenes evasion from neutrophil
killing by inhibition of the complement-derived anaphylatoxin C5a [14]. GAPDH exposed at
the surface of S. agalactiae stimulates B lymphocytes and induces an early IL-10 production
that facilitates host colonization [15]. Recently, it has been shown that S. agalactiae GAPDH
also acts as an inducer of murine macrophage apoptosis [46]. We identified a novel function of
GAPDH in S. pneumoniae as a ligand of C1q, a soluble defense collagen, which initiates the
classical complement pathway [16]. We also showed that GAPDH-C1q interaction leads to the
activation of the complement pathway in terms of C4 and C3 deposition at the bacterial sur-
face, a prerequisite step for bacterial phagocytosis by host macrophages.
The decreased level of GAPDH exposed at the surface of the lytAmutant correlates with a
lower binding to C1q in accordance with previous results where export of GAPDH was im-
paired by genetic modification [16]. We wanted to investigate in further details the role of
GAPDH regarding its interaction with the innate immune system. We fixed recombinant
pneumococcal GAPDH to purified sacculi only composed by peptidoglycan. After incubation
with human serum, C1q but not C4 was deposited to the sacculi in presence of GAPDH. This
data suggests that GAPDH alone, when associated to the peptidoglycan cell wall, is able to re-
cruit C1q but not to activate the complement pathway. It is then conceivable that the latter step
would require either other effectors at the bacterial surface (teichoic acids, proteins) or a modi-
fied form (conformational change, post-translational modification) of GAPDH not available
on the recombinant protein added exogenously. Alternatively, the C4 deposition detected inde-
pendently of the presence of GAPDH would be triggered by the complement lectin pathway ac-
tivation [62]. In conclusion, the intrinsic role of native GAPDH would be to extensively recruit
and/or consume C1q to prevent further complement activation. In this context, cell-surface at-
tached GAPDH would play a novel role in evasion of S. pneumoniae from the immune system.
Although this hypothesis requires further investigation, this strategy would be different from
recent findings showing that complement consumption is carried on through the interaction
with C1q of a soluble moonlighting protein PepO released in the culture media [63].
Methods
Pneumococcal growth conditions
Pneumococcal strains were grown at 37°C with 5% CO2 in Todd Hewitt (TH) broth or in
chemically defined C-medium supplemented with 0.1% yeast extract (CY). When indicated,
1% Choline chloride (Cho) was added to the culture media. To monitor growth curves, cells
were placed into multiwell plates within a Fluostar instrument (Optima; BMG) at 37°C where
the absorbance at 600 nm was recorded.
Production of recombinant pneumococcal GAPDH
The construction of the clone encoding the pneumococcal GAPDH protein fused to a His6-tag
at the N-terminus has been described previously [16]. Overnight culture of the E. coli BL21
(DE3)-CodonPlus-RIL (Stratagene) strain transformed with the expression construct was used
for inoculation with 500 ml of Terrific Broth medium (Euromedex) supplemented with
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100 μg/ml of ampicillin and cultured at 37°C for 3 h. Protein expression was induced with
0.5mM isopropyl-β-D-1-thiogalactopyranoside for 16 h at 15°C. After sonication and centrifu-
gation of the lysate (20 min, 40,000 x g), recombinant GAPDH was recovered from the soluble
fraction and loaded onto a 1-ml prepacked HisTrap HP column (GE Healthcare). Column
equilibration buffer was 50 mM Tris-HCl, 200 mMNaCl, 20 mM imidazole (pH 8.0). After ex-
tensive washing, His-tagged GAPDH was eluted with 60, 100, 300 and 500 mM imidazole steps
in 50 mM Tris-HCl, 200 mMNaCl (pH 8.0) buffer and subsequently dialyzed against 10 mM
HEPES, 150 mMNaCl, 2 mM CaCl2 (pH 7.4) before use for biological assays. Protein purity
was checked by Coomassie Blue staining of SDS-polyacrylamide gels. Protein concentration
was determined by absorbance at 280 nm.
FITC labeling of proteins
Pneumococcal GAPDH and other control proteins were FITC-labeled using the same protocol.
A volume of 40 μL of FITC (1 mg/mL) was added to 100 μL of purified protein at 6 mg/mL in
10 mMHEPES, 150 mMNaCl, 2 mM CaCl2 (pH 7.4). The incubation lasted for 4 h at 4°C.
The protein solution was then extensively dialyzed against 10 mMHEPES, 150 mMNaCl,
2 mM CaCl2 (pH 7.4) to remove free FITC.
Isolation of pneumococcal cell wall
Cell wall purification from S. pneumoniae R6 was adapted from [64]. Briefly, a 2 L culture in
TH was incubated at 30°C until OD600nm 0.5. Cells were harvested by centrifugation for 10 min
at 4°C at 7,500 g and resuspended in 40 ml of ice-cold water. The cell suspension was poured
dropwise into 40 ml of boiling 8% sodium dodecyl sulfate (SDS) and boiled for 45 min. Insolu-
ble polymeric peptidoglycan was pelleted by centrifugation at 20°C for 20 min at 40,000 g. The
pellet was washed with water until it was free of SDS. All centrifugation steps were performed
at 40,000 g. The pellet was resuspended in 40 ml of 20 mM phosphate buffer, 7 mM NaCl (pH
6.9) and 200 μg/ml of α-amylase (final concentration) were added. Samples were incubated for
3 h at 20°C, with gentle shaking and then centrifuged for 60 min at room temperature (RT).
The pellet was resuspended in 40 ml of 100 mM Tris (pH 8.0) and 200 μg/ml of trypsin (final
concentration) was added. Samples were incubated for 18 h at 25°C with gentle shaking and
then centrifuged for 60 min at RT. The pellet was resuspended in 40 ml of 100 mM Tris (pH
7.5) and 500 μg/ml of pronase was added. Samples were incubated for 3 h at 40°C and then
centrifuged for 60 min at RT. The pellet was washed 3 times with cold water. At this step, sam-
ples were split and half of the pellet was treated with 49% hydrofluoridic acid during 48 h at
4°C to remove teichoic acids. Hydrofluoridic acid was removed by centrifugation and both cell
wall preparations, the acid-treated and the one non treated were washed twice with 20 ml of
8 M LiCl, and then twice with 20 ml of 100 mM EDTA (pH 8.0). Cell walls were finally washed
3 times with water before being resuspended in 2 ml of water and conserved at 4°C until use.
Elution and quantification of pneumococcal surface-exposed GAPDH
The amount of surface-exposed pneumococcal GAPDH was analyzed by an alkaline elution
strategy as described previously [16]. Briefly, a 50-ml culture in late-exponential growth phase
(OD600nm 0.6) was harvested by centrifugation (15 min at 3,000 g). The cells were resuspended
in 100 mM carbonate (pH 10) buffer and incubated for 30 min at 37°C. After centrifugation
(15 min at 11,000 g), the pellet (cytoplasmic extract) and the alkaline supernatant (surface-as-
sociated fraction) were collected. Proteins were separated by SDS-PAGE, transferred on a ni-
trocellulose membrane and analyzed by Western blot using rabbit anti-pneumococcal
GAPDH serum (1:5,000 dilution), horseradish peroxidase-conjugated anti-rabbit antibody
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(1:5,000 dilution, Sigma Aldrich) and ECL (Pierce) as detection reagent. The intensity of the
spots was quantified using the ImageJ software. The amount of GAPDH in each sample was
determined related to the GAPDH released by the wild-type strain. Pneumococcal FtsZ was de-
tected using polyclonal rabbit serum.
Microscopy techniques
After incubation with FITC-labeled GAPDH, cell wall sacculi suspensions were washed and de-
posited on microscope slides. Buffer removed after dialysis of FITC-labeled GAPDH was used
as a negative control to verify that sacculi labeling would not be due to remaining free FITC
molecules. Slides were observed using an Olympus BX61 optical microscope equipped with a
UPFLN 100¥ O-2PH/1.3 objective and a QImaging Retiga-SRV 1394 cooled charge-coupled
device camera. Image acquisition was performed using the Volocity software package and pro-
cessed with Adobe Photoshop 6.0.
Pneumococcal subcellular fractionation
The amount of pneumococcal GAPDH in the cell wall compartment of the R6 wild-type strain
grown in CY or in CY supplemented with 1% Cho and of the lytAmutant in CY was analyzed
by cell fractionation. One-tenth of a 100-ml culture in late exponential growth phase (OD600nm
0.6) was centrifuged (15 min at 3,000 g), and the pellet was resuspended in 1 ml of PBS contain-
ing 100 μg/ml lysozyme and 50 U/ml mutanolysin and incubated for 2 h at 37°C. The lysate
samples were submitted to SDS-PAGE and stained by Coomassie blue. The total amount of
proteins in each sample was quantified using the ImageJ software in order to correct, if neces-
sary, equivalent loads of samples. The remaining 90 ml were centrifuged (15 min, 3,000 g), the
pellet was resuspended in 9 ml of PBS containing 100 μg/ml lysozyme, 50 U/ml mutanolysin,
30% sucrose and incubated for 2 h at 37°C. This lysate was centrifuged and the supernatant
containing the cell wall was collected. The cell wall fractions were separated by SDS-PAGE,
transferred on a nitrocellulose membrane and analyzed by Western blot using rabbit anti-
pneumococcal GAPDH antibody (1:5,000 dilution), horseradish peroxidase-conjugated anti-
rabbit antibody (1:5,000 dilution, Sigma Aldrich) and ECL (Pierce) as detection reagent. The
intensity of the spots was quantified using the ImageJ software.
FITC-labeled proteins binding to pneumococcal sacculi
Five mg of cell wall pneumococcal sacculi were resuspended with 50 μl of each FITC-labelled
proteins at 1 mg/ml in 10 mMHEPES, 150 mMNaCl, 2 mM CaCl2 (pH 7.4) and incubated for
1 h at RT. Sacculi were centrifuged (5 min at 20,000 g), supernatants were removed and the pel-
lets were resuspended in 1 mL of 10 mMHEPES, 150 mMNaCl, 2 mM CaCl2 (pH 7.4). This
washing step was repeated five times. The sacculi pellets were finally resuspended in 50 μL of
10 mMHEPES, 150 mMNaCl, 2 mM CaCl2 (pH 7.4) and transferred into a black 96-well mi-
crotiter plate (Greiner Bio One). Bound proteins to pneumococcal sacculi were detected by
fluorescence measurements (Fluostar Optima; BMG). Each experiment was performed in
duplicate.
Cell wall pull-down binding assay
GAPDH (10 μg/ml) was incubated with 5 mg of purified pneumococcal cell wall containing
both PG and TA components in 50 μl of 10 mMHEPES, 150 mMNaCl, 2 mM CaCl2 (pH 7.4)
for 16 h at 4°C. After centrifugation (5 min at 5,000 g), the supernatant was removed and the
cell wall pellet was washed three times and resuspended in 50 μl Laemmli buffer. After
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incubation at 100°C for 10 min and a centrifugation step (3 min at 5,000 g), the supernatant
fraction containing the eluted cell wall-bound protein was recovered. Load, supernatant, wash
and bound fractions were analyzed by Western blotting using HRP-conjugated anti-His tag
monoclonal antibody diluted 1:10 000 before detection with a chemiluminescent substrate
(ECL; Thermo Scientific Pierce).
Bacterial binding assay to C1q
Solid-phase binding assays were performed to measure binding of the R6 wild-type and lytA
mutant strains to C1q. Black 96-well microtiter plates (Greiner Bio One) were coated in tripli-
cates with 1 μg of C1q or gelatin in PBS at 4°C overnight. Saturation was performed by adding
200 μl/well of 0.2% gelatin in 10mMHEPES, 150mMNaCl, 2mM CaCl2 (pH 7.4) (HBS-C) for
1 h at RT. Five washes were performed using 200 μl of HBS-C. 100 μl of FITC-labeled bacteria
(7,5.106 CFU) were added to each well, and the mixture was incubated for 1 h at RT. Five
washes were performed using 200 μl of HBS-C. The bacteria-associated fluorescence was mea-
sured using a multiwell fluorescence reader (Fluostar Optima, BMG Labtech).
Complement deposition on pneumococcal sacculi and on pneumococci
cells
White 96-well microtiter plates (Greiner Bio One) were coated in triplicates with 100 μg of pu-
rified pneumococcal sacculi containing only the peptidoglycan (PG) in TBS-C (50 mM Tris
pH 8.0, 100 mMNaCl, 2 mM CaCl2). Saturation was performed by adding 200 μl of TBS-C-
0.2% gelatin per well for 1 h at RT. Three washes were performed using 200 μl of TBS-C.
Whenever required, 100 μl of GAPDH at 10 μg/ml in TBS-C was added, and the mixture was
incubated for 1 h at RT. Normal Human Serum (NHS) diluted 1:25 in TBS-C was added and
incubated for 1 h at RT. Three washes were performed using 200 μl of TBS-C. Bound C1q and
C4 proteins were detected by adding 100 μl of rabbit anti-C1q (in house production) and rabbit
anti-C4 (Abcam ab48612) antibodies (1:1,000 dilution) in TBS-C-0.02% gelatin for 1 h at RT.
Following washes, secondary antibodies coupled to horseradish peroxidase (1:1,000 dilution)
in TBS-C-0.02% gelatin were incubated for 1 h at RT. After three washes with TBS-C, ECL so-
lution (Pierce) (100 μl) was added to each well and chemiluminescence was measured using a
multiwell luminescence reader (Fluostar Optima; BMG).
Solid-phase binding assay on pneumococcal sacculi
Purified pneumococcal sacculi containing the peptidoglycan (PG) and the teichoic acids (TA)
components, or only the PG were used. Purified LTA from S. pneumoniae was purchased from
Statens Serum Institute (Denmark) and human CRP from Calbiochem (236608). White
96-well microtiter plates (Greiner Bio One) were coated in triplicates with 100 μg of the differ-
ent polysaccharide reagents. Saturation was performed by adding 200 μl of PBS-0.2% gelatin
per well for 1 h at RT. Three washes were performed using 200 μl of PBS. A volume of 100 μl of
GAPDH and CRP at 10 μg/ml in PBS was added to each well, and the mixture was incubated
for 2 h at RT. Three washes were performed using 200 μl of PBS-0.2% Tween 20. Bound pro-
teins were detected by adding 100 μl of mouse anti-His tag and goat anti-CRP antibodies cou-
pled to horseradish peroxidase (1:1,000 dilution) in PBS-0.02% Tween 20–0.02% gelatin for 2 h
at RT. After three washes with PBS-0.2% Tween-20, ECL solution (Pierce) (100 μl) was added
to each well and chemiluminescence was measured using a multiwell luminescence reader
(Fluostar Optima; BMG).
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